肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2007年
z1期
39-40
,共2页
子宫肿瘤%化疗栓塞%治疗性
子宮腫瘤%化療栓塞%治療性
자궁종류%화료전새%치료성
Uterine neoplasms%Chemoembolization,therapeutic
目的 探讨动脉化疗栓塞在晚期子宫癌治疗中的临床价值.方法 52例子宫癌,其中子宫颈癌43例,子宫体癌9例.全部病例均行术前介入治疗,其中45例介入治疗1~2次后10~14 d行广泛的子宫切除+盆腔淋巴结清扫;另有7例未能手术的患者仍继续行姑息介入治疗.结果 近期疗效显著,症状明显缓解,术中出血量减少,肿瘤容易剥离.手术的45例患者中,1年和3年生存率分别为100%和92%;7例行单纯动脉化疗栓塞的患者,1年和3年生存率分别为100%和85%.结论 术前介入治疗能降低子宫癌的临床分期,减少淋巴结转移,提高手术切除率.联合手术治疗能明显延长患者生存期,可作为子宫癌的常规治疗推广应用.
目的 探討動脈化療栓塞在晚期子宮癌治療中的臨床價值.方法 52例子宮癌,其中子宮頸癌43例,子宮體癌9例.全部病例均行術前介入治療,其中45例介入治療1~2次後10~14 d行廣汎的子宮切除+盆腔淋巴結清掃;另有7例未能手術的患者仍繼續行姑息介入治療.結果 近期療效顯著,癥狀明顯緩解,術中齣血量減少,腫瘤容易剝離.手術的45例患者中,1年和3年生存率分彆為100%和92%;7例行單純動脈化療栓塞的患者,1年和3年生存率分彆為100%和85%.結論 術前介入治療能降低子宮癌的臨床分期,減少淋巴結轉移,提高手術切除率.聯閤手術治療能明顯延長患者生存期,可作為子宮癌的常規治療推廣應用.
목적 탐토동맥화료전새재만기자궁암치료중적림상개치.방법 52례자궁암,기중자궁경암43례,자궁체암9례.전부병례균행술전개입치료,기중45례개입치료1~2차후10~14 d행엄범적자궁절제+분강림파결청소;령유7례미능수술적환자잉계속행고식개입치료.결과 근기료효현저,증상명현완해,술중출혈량감소,종류용역박리.수술적45례환자중,1년화3년생존솔분별위100%화92%;7례행단순동맥화료전새적환자,1년화3년생존솔분별위100%화85%.결론 술전개입치료능강저자궁암적림상분기,감소림파결전이,제고수술절제솔.연합수술치료능명현연장환자생존기,가작위자궁암적상규치료추엄응용.
Objective To evaluate the clinical value of arterial chemotherapy and embolization in the treatment of advanced uterine carcinoma.Methods In this study,52 cases of uterine carcinoma(including 43 carcinoma of cervix and 9 cases carcinoma of endonetrium)were treated interventional therapy.In these cases,after one or two times interventional therapy and after 10-14 days,45 cases followed by uterectomy and pelvic lymphadenectomy. 7 cases that can't operated continue followed by interventional therapy. Results Curative effect was obvious,the clinical symptoms were alleviated,the bleed in operation was decreased and the tumor was divided easily.In 45 cases followed by operation,the one-year and three-year survival rate are 100% and 92%.In 7 cases treated by interventional therapy alone,the one-year and three-year survival rate are 100% and 85%.Conlusion The interventional therapy preoperation can reduce the clinical stage and metastasis of lymph,improve the ectomy by operation and survival rate of patients obviously,so it can be used as a routine treatment in uterine carcinoma.